Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73926 - 73950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR1178	100302274	upregulated	Silver analog results in increased expression of MIR1178 mRNA	12q24.23	A24215
Silver	Approved Investigational	MIR1181	100302213	downregulated	Silver analog results in decreased expression of MIR1181 mRNA	19p13.2	A24215
Silver	Approved Investigational	MIR1181	100302213	downregulated	Silver results in decreased expression of MIR1181 mRNA	19p13.2	A24215
Silver	Approved Investigational	MIR1224	100187716	upregulated	Silver analog results in increased expression of MIR1224 mRNA	3q27.1	A24215
Silver	Approved Investigational	MIR1225	100188847	downregulated	Silver analog results in decreased expression of MIR1225 mRNA	16p13.3	A24215
Silver	Approved Investigational	MIR1226	100302232	downregulated	Silver results in decreased expression of MIR1226 mRNA	3p21.31	A24216
Silver	Approved Investigational	MIR1229	100302156	upregulated	Silver analog results in increased expression of MIR1229 mRNA	5q35.3	A24215
Silver	Approved Investigational	MIR1229	100302156	upregulated	Silver results in increased expression of MIR1229 mRNA	5q35.3	A24215
Silver	Approved Investigational	MIR1238	100302226	downregulated	Silver analog results in decreased expression of MIR1238 mRNA	19p13.2	A24215
Silver	Approved Investigational	MIR1238	100302226	downregulated	Silver results in decreased expression of MIR1238 mRNA	19p13.2	A24215
Silver	Approved Investigational	MIR1247	100302145	upregulated	Silver results in increased expression of MIR1247 mRNA	14q32.31	A24216
Silver	Approved Investigational	MIR1248	100302143	downregulated	Silver analog results in decreased expression of MIR1248 mRNA	3q27.3	A24215
Silver	Approved Investigational	MIR1248	100302143	downregulated	Silver results in decreased expression of MIR1248 mRNA	3q27.3	A24215
Silver	Approved Investigational	MIR1255A	100302193	upregulated	Silver results in increased expression of MIR1255A mRNA	4q24	A24216
Silver	Approved Investigational	MIR1257	100302168	upregulated	Silver analog results in increased expression of MIR1257 mRNA	20q13.33	A24215
Silver	Approved Investigational	MIR1275	100302123	upregulated	Silver results in increased expression of MIR1275 mRNA	6p21.31	A24216
Silver	Approved Investigational	MIR1281	100302237	downregulated	Silver analog results in decreased expression of MIR1281 mRNA	22q13.2	A24215
Silver	Approved Investigational	MIR1281	100302237	downregulated	Silver results in decreased expression of MIR1281 mRNA	22q13.2	A24215
Silver	Approved Investigational	MIR1290	100302276	downregulated	Silver analog results in decreased expression of MIR1290 mRNA	1p36.13	A24215
Silver	Approved Investigational	MIR1290	100302276	downregulated	Silver results in decreased expression of MIR1290 mRNA	1p36.13	A24215
Silver	Approved Investigational	MIR132	406921	upregulated	Silver results in increased expression of MIR132 mRNA	17p13.3	A24216
Silver	Approved Investigational	MIR138-1	406929	upregulated	Silver analog results in increased expression of MIR138-1 mRNA	3p21.32	A24215
Silver	Approved Investigational	MIR140	406932	downregulated	Silver analog results in decreased expression of MIR140 mRNA	16q22.1	A24215
Silver	Approved Investigational	MIR141	406933	downregulated	Silver analog results in decreased expression of MIR141 mRNA	12p13.31	A24215
Silver	Approved Investigational	MIR150	406942	downregulated	Silver results in decreased expression of MIR150 mRNA	19q13.33	A24216

Displaying entries 73926 - 73950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability